PubRank

T E Cawston

Author PubWeight™ 111.54‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A rapid and reproducible assay for collagenase using [1-14C]acetylated collagen. Anal Biochem 1979 3.17
2 Purification and characterization of a rabbit bone metalloproteinase that degrades proteoglycan and other connective-tissue components. Biochem J 1983 2.17
3 Purification of rabbit bone inhibitor of collagenase. Biochem J 1981 2.12
4 Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up. Ann Rheum Dis 1989 1.81
5 An association between the CTLA4 exon 1 polymorphism and early rheumatoid arthritis with autoimmune endocrinopathies. Rheumatology (Oxford) 2002 1.74
6 Rotator cuff degeneration and lateral epicondylitis: a comparative histological study. Ann Rheum Dis 1994 1.73
7 The interaction of purified rabbit bone collagenase with purified rabbit bone metalloproteinase inhibitor. Biochem J 1983 1.72
8 Actions of IL-1 are selectively controlled by p38 mitogen-activated protein kinase: regulation of prostaglandin H synthase-2, metalloproteinases, and IL-6 at different levels. J Immunol 1997 1.64
9 Metalloproteinases from rabbit bone culture medium degrade types IV and V collagens, laminin and fibronectin. Biochem J 1981 1.62
10 The measurement of collagenase, tissue inhibitor of metalloproteinases (TIMP), and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 1993 1.62
11 Tendon degeneration and chronic shoulder pain: changes in the collagen composition of the human rotator cuff tendons in rotator cuff tendinitis. Ann Rheum Dis 1994 1.58
12 Fragments of human fibroblast collagenase. Purification and characterization. Biochem J 1989 1.55
13 Purification of pig synovial collagenase to high specific activity. Biochem J 1979 1.53
14 An inhibitor of collagenase from human amniotic fluid. Purification, characterization and action on metalloproteinases. Biochem J 1981 1.52
15 The modulation of matrix metalloproteinase and ADAM gene expression in human chondrocytes by interleukin-1 and oncostatin M: a time-course study using real-time quantitative reverse transcription-polymerase chain reaction. Arthritis Rheum 2002 1.52
16 Structure of full-length porcine synovial collagenase reveals a C-terminal domain containing a calcium-linked, four-bladed beta-propeller. Structure 1995 1.44
17 Glycosaminoglycans of human rotator cuff tendons: changes with age and in chronic rotator cuff tendinitis. Ann Rheum Dis 1994 1.43
18 Distribution of collagenase and tissue inhibitor of metalloproteinases (TIMP) in colorectal tumours. Int J Cancer 1991 1.34
19 Phenotype of airway epithelial cells suggests epithelial to mesenchymal cell transition in clinically stable lung transplant recipients. Thorax 2005 1.33
20 Synergistic effects of glycoprotein 130 binding cytokines in combination with interleukin-1 on cartilage collagen breakdown. Arthritis Rheum 2001 1.31
21 Metalloproteinases and collagenase inhibitors in rheumatoid synovial fluid. Arthritis Rheum 1984 1.31
22 Interleukin 17 induces cartilage collagen breakdown: novel synergistic effects in combination with proinflammatory cytokines. Ann Rheum Dis 2002 1.31
23 Activation of procollagenases is a key control point in cartilage collagen degradation: interaction of serine and metalloproteinase pathways. Arthritis Rheum 2001 1.24
24 Primary airway epithelial cell culture from lung transplant recipients. Eur Respir J 2005 1.23
25 Characterization of a specific antiserum for mammalian collagenase from several species: immunolocalization of collagenase in rabbit chondrocytes and uterus. J Cell Sci 1986 1.22
26 Human shoulder tendon biopsy samples in organ culture produce procollagenase and tissue inhibitor of metalloproteinases. Ann Rheum Dis 1995 1.22
27 Measurement of rheumatoid factors by an enzyme-linked immunosorbent assay (ELISA) and comparison with other methods. Ann Rheum Dis 1985 1.20
28 Differential Toll-like receptor-dependent collagenase expression in chondrocytes. Ann Rheum Dis 2008 1.19
29 Oncostatin M in combination with tumor necrosis factor alpha induces cartilage damage and matrix metalloproteinase expression in vitro and in vivo. Arthritis Rheum 2003 1.15
30 Early joint erosions and serum levels of matrix metalloproteinase 1, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinases 1 in rheumatoid arthritis. Arthritis Rheum 2001 1.13
31 Identification of plasma kallikrein as an activator of latent collagenase in rheumatoid synovial fluid. Biochim Biophys Acta 1982 1.13
32 Collagenase: a key enzyme in collagen turnover. Biochem Cell Biol 1996 1.12
33 Collagenase (MMP-1) and TIMP-1 in destructive corneal disease associated with rheumatoid arthritis. Eye (Lond) 1995 1.12
34 The prevention of collagen breakdown in bovine nasal cartilage by TIMP, TIMP-2 and a low molecular weight synthetic inhibitor. Biochem Biophys Res Commun 1994 1.10
35 Matrix metalloproteinase 10 promotion of collagenolysis via procollagenase activation: implications for cartilage degradation in arthritis. Arthritis Rheum 2006 1.10
36 Prevalence and possible pathological significance of calcium phosphate salt accumulation in tendon matrix degeneration. Ann Rheum Dis 1996 1.08
37 Monoclonal antibodies against human fibroblast collagenase and the design of an enzyme-linked immunosorbent assay to measure total collagenase. Matrix 1992 1.07
38 Serum TIMP-1, TIMP-2, and MMP-1 in patients with systemic sclerosis, primary Raynaud's phenomenon, and in normal controls. Ann Rheum Dis 2001 1.06
39 Tenascin-C and human tendon degeneration. Am J Pathol 1996 1.06
40 Mammalian collagenases. Methods Enzymol 1981 1.04
41 Interleukin-1 in combination with oncostatin M up-regulates multiple genes in chondrocytes: implications for cartilage destruction and repair. Arthritis Rheum 2006 1.04
42 Idiopathic haemorrhagic rupture of the shoulder in destructive disease of the elderly. Ann Rheum Dis 1986 0.99
43 Interleukin 13 blocks the release of collagen from bovine nasal cartilage treated with proinflammatory cytokines. Ann Rheum Dis 2001 0.99
44 Preferential binding of collagenase to alpha 2-macroglobulin in the presence of the tissue inhibitor of metalloproteinases. FEBS Lett 1986 0.99
45 Synergistic induction of matrix metalloproteinase 1 by interleukin-1alpha and oncostatin M in human chondrocytes involves signal transducer and activator of transcription and activator protein 1 transcription factors via a novel mechanism. Arthritis Rheum 2001 0.99
46 The platelet reactivity of collagen type I: evidence for multiple platelet-reactive sites in the type I collagen molecule. Thromb Haemost 1986 0.96
47 Transforming growth factor-beta causes partial inhibition of interleukin 1-stimulated cartilage degradation in vitro. Biochem Biophys Res Commun 1989 0.96
48 Properties of pig synovial collagenase. Biochem J 1980 0.96
49 Retinoic acid combines with interleukin-1 to promote the degradation of collagen from bovine nasal cartilage: matrix metalloproteinases-1 and -13 are involved in cartilage collagen breakdown. J Cell Biochem 2000 0.95
50 Transcriptional activity of the human tissue inhibitor of metalloproteinases 1 (TIMP-1) gene in fibroblasts involves elements in the promoter, exon 1 and intron 1. Biochem J 1997 0.95
51 The biology of integration of the anterior cruciate ligament. J Bone Joint Surg Br 2005 0.94
52 A synthetic peptide metalloproteinase inhibitor, but not TIMP, prevents the breakdown of proteoglycan within articular cartilage in vitro. Agents Actions 1992 0.94
53 Transforming growth factor beta stimulates the production of the tissue inhibitor of metalloproteinases (TIMP) by human synovial and skin fibroblasts. Biochim Biophys Acta 1991 0.93
54 Oncostatin M in combination with tumour necrosis factor {alpha} induces a chondrocyte membrane associated aggrecanase that is distinct from ADAMTS aggrecanase-1 or -2. Ann Rheum Dis 2005 0.93
55 An aggrecan-degrading activity associated with chondrocyte membranes. Biochem J 1998 0.92
56 Development of an enzyme-linked immunosorbent assay to measure total TIMP-1 (free TIMP-1 and TIMP-1 in combination with matrix-metalloproteinases) and measurement of TIMP 1 and CRP in serum. Clin Chim Acta 1995 0.92
57 The activation of latent pig synovial collagenase. Biochim Biophys Acta 1981 0.92
58 Tissue inhibitor of metalloproteinases (TIMP-1) stimulates the secretion of collagenase from human skin fibroblasts. Biochem Biophys Res Commun 1994 0.92
59 Assessment of the clinical significance of gelatinase activity in patients with juvenile idiopathic arthritis using quantitative protein substrate zymography. Ann Rheum Dis 2005 0.91
60 96-Well plate assays for measuring collagenase activity using (3)H-acetylated collagen. Anal Biochem 1999 0.91
61 Rheumatoid factors in association with rheumatoid arthritis and infectious diseases in West Africans. J Rheumatol 1994 0.91
62 Involvement of a region near valine-69 of tissue inhibitor of metalloproteinases (TIMP)-1 in the interaction with matrix metalloproteinase 3 (stromelysin 1). Biochem J 1997 0.89
63 Levels of matrix metalloproteinase (MMP)-1 in paired sera and synovial fluids of juvenile idiopathic arthritis patients: relationship to inflammatory activity, MMP-3 and tissue inhibitor of metalloproteinases-1 in a longitudinal study. Rheumatology (Oxford) 2005 0.88
64 Development of a novel 2D proteomics approach for the identification of proteins secreted by primary chondrocytes after stimulation by IL-1 and oncostatin M. Rheumatology (Oxford) 2006 0.88
65 Inhibition of furin-like enzymes blocks interleukin-1alpha/oncostatin M-stimulated cartilage degradation. Arthritis Rheum 2003 0.88
66 Metalloproteinases in the rheumatic diseases. J Pathol 1996 0.88
67 The binding of rabbit bone inhibitor of collagenase to concanavalin A--Sepharose [proceedings]. Biochem Soc Trans 1980 0.88
68 Purification of a metalloproteinase inhibitor from human rheumatoid synovial fluid. Biochem J 1985 0.88
69 Large inhibitor of metalloproteinases (LIMP) contains tissue inhibitor of metalloproteinases (TIMP)-2 bound to 72,000-M(r) progelatinase. Biochem J 1992 0.86
70 Interleukin-6 signalling in juvenile idiopathic arthritis is limited by proteolytically cleaved soluble interleukin-6 receptor. Rheumatology (Oxford) 2006 0.85
71 Inhibition of interleukin-1-induced collagenase production in human articular chondrocytes in vitro by recombinant human interferon-gamma. Arthritis Rheum 1990 0.85
72 Polyclonal antibodies against human fibroblast collagenase and the design of an enzyme-linked immunosorbent assay to measure TIMP-collagenase complex. Matrix 1992 0.84
73 Gingival fibroblasts grown from cyclosporin-treated patients show a reduced production of matrix metalloproteinase-1 (MMP-1) compared with normal gingival fibroblasts, and cyclosporin down-regulates the production of MMP-1 stimulated by pro-inflammatory cytokines. J Periodontal Res 2007 0.84
74 The secretion of the tissue inhibitor of metalloproteinases (TIMP) by human synovial fibroblasts is modulated by all-trans-retinoic acid. Biochim Biophys Acta 1991 0.84
75 Tissue inhibitor of metalloproteinases: serum levels during pregnancy and labor, term and preterm. Obstet Gynecol 1994 0.83
76 Crystallization and preliminary X-ray analysis of porcine synovial collagenase. J Mol Biol 1989 0.83
77 Polyclonal and monoclonal antibodies against human tissue inhibitor of metalloproteinases (TIMP) and the design of an enzyme-linked immunosorbent assay to measure TIMP. Matrix 1991 0.83
78 A rapid and reproducible method for the analysis of immune complexes using affinity chromatography and Western blotting. J Immunol Methods 1985 0.83
79 Human nasal cartilage responds to oncostatin M in combination with interleukin 1 or tumour necrosis factor alpha by the release of collagen fragments via collagenases. Ann Rheum Dis 2005 0.83
80 Isolation and analysis of immune complexes from sera of patients with polymyalgia rheumatica and giant cell arteritis. Ann Rheum Dis 1987 0.82
81 Isolation, preparation and the amino acid composition of 4 milk-fat globule membrane proteins solubilized by treatment with sodium dodecyl sulphate. J Dairy Res 1976 0.81
82 Mechanisms of induction of human tissue inhibitor of metalloproteinases-1 (TIMP-1) gene expression by all-trans retinoic acid in combination with basic fibroblast growth factor. Eur J Biochem 2000 0.81
83 Markers of joint destruction: principles, problems, and potential. Ann Rheum Dis 2001 0.81
84 Cartilage canals in equine articular/epiphyseal growth cartilage and a possible association with dyschondroplasia. Equine Vet J 1997 0.81
85 The sulphated glycosaminoglycan levels in synovial fluid aspirates in patients with acute and chronic joint disease. Br J Rheumatol 1990 0.81
86 Esculetin inhibits cartilage resorption induced by interleukin 1alpha in combination with oncostatin M. Ann Rheum Dis 2001 0.80
87 Rapid purification of tissue inhibitor of metalloproteinases from human plasma and identification as a gamma-serum protein. Biochem J 1986 0.80
88 Serum alpha 1 antichymotrypsin concentration as a marker of disease activity in rheumatoid arthritis. Ann Rheum Dis 1988 0.80
89 A fibroblast elongation factor purified from colon carcinoma cells shares sequence identity with TIMP-1. Biochem Biophys Res Commun 1995 0.80
90 Preparation of recombinant tissue inhibitor of metalloproteinases-1 (TIMP-1) in high yield and identification of a hydrophobic surface feature. Eur J Biochem 1998 0.79
91 Specificity of IgM antiglobulins produced in rheumatoid arthritis and tropical infections. Clin Rheumatol 1995 0.79
92 Retinoic acid and oncostatin M combine to promote cartilage degradation via matrix metalloproteinase-13 expression in bovine but not human chondrocytes. Rheumatology (Oxford) 2006 0.79
93 A computer simulation approach to assessing therapeutic intervention points for the prevention of cytokine-induced cartilage breakdown. Arthritis Rheumatol 2014 0.79
94 Human lung mast cell tryptase fails to activate procollagenase or degrade proteoglycan. Biochem Biophys Res Commun 1985 0.78
95 Induction of human tissue inhibitor of metalloproteinase-1 gene expression by all-trans retinoic acid in combination with basic fibroblast growth factor involves both p42/44 and p38 MAP kinases. Ann N Y Acad Sci 1999 0.78
96 Circulating levels of IL-1beta, IL-6 and soluble IL-2 receptor in polymyalgia rheumatica and giant cell arteritis and rheumatoid arthritis. Br J Rheumatol 1998 0.78
97 Routine quantitation of rheumatoid factors: ELISA or nephelometry? Scand J Rheumatol 1992 0.77
98 Fragments of human fibroblast collagenase: interaction with metalloproteinase inhibitors and substrates. Biochim Biophys Acta 1994 0.77
99 Prevention of cartilage breakdown by matrix metalloproteinase inhibition--a realistic therapeutic target? Br J Rheumatol 1998 0.77
100 Serum MMP-1 and TIMP-1 levels are increased in patients with psoriatic arthritis and their siblings. Rheumatology (Oxford) 2003 0.77
101 Stabilisation of purified human collagenase by site-directed mutagenesis. Biochem Biophys Res Commun 1995 0.76
102 Rheumatoid factor and rheumatoid factor isotypes in loiasis with and without accompanying glomerulonephritis. Trans R Soc Trop Med Hyg 1993 0.76
103 The effect of the anabolic steroid, stanozolol, on the production of procollagenase by human synovial and skin fibroblasts in vitro. Agents Actions 1989 0.76
104 Salmonella enteritidis causing joint sepsis. Clin Rheumatol 1990 0.75
105 High free and latent collagenase activity in psoriatic arthritis synovial fluid. Br J Rheumatol 1995 0.75
106 Nucleotide sequence of a cDNA for porcine type I collagenase, obtained by PCR. Nucleic Acids Res 1990 0.75
107 Fragments of human fibroblast collagenase: purification and characterisation. Matrix Suppl 1992 0.75
108 All-trans-retinoic acid interacts synergistically with basic fibroblast growth factor and epidermal growth factor to stimulate the production of tissue inhibitor of metalloproteinases from fibroblasts. Arch Biochem Biophys 1995 0.75
109 The measurement of human collagenase-TIMP complex by enzyme immunoassay. Biochem Soc Trans 1991 0.75
110 The differential responses of human skin and synovial fibroblasts to stanozolol in vitro: production of prostaglandin E2 and matrix metalloproteinases. Agents Actions 1992 0.75
111 Production in Escherichia coli of porcine type-I collagenase as a fusion protein with beta-galactosidase. Gene 1992 0.75
112 Milwaukee shoulder--synovial fluid contains no active collagenase. Br J Rheumatol 1987 0.75
113 Modulation of plasminogen activator production by interleukin 1: differential responses of fibroblasts derived from human skin and rheumatoid and non-rheumatoid synovium. Biochim Biophys Acta 1990 0.75
114 Effect of retinoic acid in combination with platelet-derived growth factor-BB or transforming growth factor-beta on tissue inhibitor of metalloproteinases and collagenase secretion from human skin and synovial fibroblasts. J Cell Physiol 1996 0.75
115 Rheumatoid factor quantitation: a comparison of ELISA and nephelometric methods. Med Lab Sci 1991 0.75
116 The differential effects of stanozolol on human skin and synovial fibroblasts in vitro: DNA synthesis and receptor binding. Agents Actions 1994 0.75
117 Tissue collagenase: serum levels during pregnancy and parturition. Eur J Obstet Gynecol Reprod Biol 1994 0.75
118 Cloning of a cDNA for porcine type I collagenase and expression in E. coli. Biochem Soc Trans 1991 0.75
119 Recombinant porcine collagenase: purification and autolysis. Arch Biochem Biophys 1995 0.75
120 Connective tissue catabolism in relation to the cornea. Trans Ophthalmol Soc U K 1978 0.75
121 Purification and secondary structural analysis of tissue inhibitor of metalloproteinases-1. Biochim Biophys Acta 1994 0.75